0000950170-24-052964.txt : 20240503
0000950170-24-052964.hdr.sgml : 20240503
20240503163047
ACCESSION NUMBER: 0000950170-24-052964
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240501
FILED AS OF DATE: 20240503
DATE AS OF CHANGE: 20240503
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hassanein Waleed H
CENTRAL INDEX KEY: 0001430466
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38891
FILM NUMBER: 24913682
MAIL ADDRESS:
STREET 1: TRANSMEDICS INC
STREET 2: 200 MINUTEMAN ROAD
CITY: ANDOVER
STATE: MA
ZIP: 01810
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: TransMedics Group, Inc.
CENTRAL INDEX KEY: 0001756262
STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 000000000
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 200 MINUTEMAN ROAD
CITY: ANDOVER
STATE: MA
ZIP: 01810
BUSINESS PHONE: 9785520900
MAIL ADDRESS:
STREET 1: 200 MINUTEMAN ROAD
CITY: ANDOVER
STATE: MA
ZIP: 01810
4
1
ownership.xml
4
X0508
4
2024-05-01
0001756262
TransMedics Group, Inc.
TMDX
0001430466
Hassanein Waleed H
C/O TRANSMEDICS GROUP, INC.
200 MINUTEMAN ROAD
ANDOVER
MA
01810
true
true
false
false
President & CEO
true
Common Stock
2024-05-01
4
M
false
56000
13.28
A
130087
D
Common Stock
2024-05-01
4
S
false
2685
105.56
D
127402
D
Common Stock
2024-05-01
4
S
false
91
106.51
D
127311
D
Common Stock
2024-05-01
4
S
false
424
107.57
D
126887
D
Common Stock
2024-05-01
4
S
false
6800
110.00
D
120087
D
Common Stock
2024-05-01
4
S
false
23500
114.17
D
96587
D
Common Stock
2024-05-01
4
S
false
22500
120.25
D
74087
D
Common Stock
2024-05-02
4
S
false
6140
120.64
D
67947
D
Common Stock
2024-05-02
4
S
false
6222
122.16
D
61725
D
Common Stock
2024-05-02
4
S
false
82
122.67
D
61643
D
Common Stock
469359
I
By the Waleed H. Hassanein Revocable Trust
Stock Option (Right to Buy)
13.28
2024-05-01
4
M
false
56000
0.00
D
2032-02-22
Common Stock
56000
178000
D
The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023.
The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $105.50 to $106.17, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $107.56 to $107.66, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $114.00 to $114.41, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $120.00 to $120.74, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $120.22 to $120.995, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $121.66 to $122.51, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on February 22, 2026.
By: /s/ Stephen Gordon, Attorney-in-Fact
2024-05-03